Latest IR information
IR News
- 2025.09.17
- SymBio Secures EMA Approval of the Pediatric Investigation Plan (PIP) for IV Brincidofovir, a Requirement for Initiating the Global Phase 3 Study for Adenovirus Infection following HSCT
- 2025.09.01
- Notice Regarding the Monthly Exercise Status of the 58th and 65th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued through Third-Party Allotment
- 2025.08.26
- Notice Regarding the Completion of Payment for the 1st Unsecured Straight Bonds
- 2025.08.12
- Notice Regarding the Completion of Payment for the Issue Price of the Issuance of the 65th to 67th Stock Acquisition Rights (with Exercise Price Adjustment Clauses) through Third-Party Allotment
- 2025.08.12
- Notice Regarding Adjustment of Conversion Price